INTRODUCTION
============

Coronavirus disease 2019 (COVID-19) is the result of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ^\[[@b1-1672-1-12952-1-10-20200422]\]^. Cardiac involvement in COVID-19 is being increasingly recognized and may indicate a poor outcome ^\[[@b2-1672-1-12952-1-10-20200422]\]^. While patients with COVID-19 can develop acute coronary syndrome, ST segment elevation on electrocardiogram (ECG) has been mainly described in patients with COVID-19-related acute myocarditis and severely reduced left ventricular ejection fraction (LVEF) ^\[[@b2-1672-1-12952-1-10-20200422]--[@b5-1672-1-12952-1-10-20200422]\]^. We describe two cases of transient ST segment elevation in patients with preserved LVEF. Our goal is to raise awareness of this aspect of cardiovascular involvement in COVID-19 and prevent unnecessary catheterization.

CASE DESCRIPTION
================

Case 1
------

A 64-year-old male patient with a medical history of hypertension and hyperlipidaemia presented to the emergency room with a 3-day history of dyspnoea. His blood pressure at presentation was 85/51 mmHg, heart rate was 80 beats per minute, respiratory rate was 36 breaths per minute and oxygen saturation was 70% on room air. The patient was intubated, mechanically ventilated, started on norepinephrine for hypotension and admitted to the medical intensive care unit (MICU). The patient's chest x-ray is shown in [Fig. 1](#f1-1672-1-12952-1-10-20200422){ref-type="fig"}.

A baseline ECG showed non-specific T wave changes but did not demonstrate acute ischaemic changes or arrhythmia ([Fig. 2](#f2-1672-1-12952-1-10-20200422){ref-type="fig"}). The patient's baseline troponin was 0.17 ng/ml. On day 2 of hospitalization, the patient's hypoxia worsened, requiring maximum ventilatory support and sedation. A repeat ECG showed ST segment elevation i\\n leads I, aVL and V1--V4 and reciprocal ST depression in leads II, III and aVF ([Fig. 3](#f3-1672-1-12952-1-10-20200422){ref-type="fig"}).

Due to the patient's life-threatening respiratory failure, it was decided not to pursue reperfusion therapy. After administration of loading doses, aspirin 81 mg, clopidogrel 75 mg and a heparin drip were initiated. The patient's other medications included azithromycin, hydroxychloroquine, meropenem, tocilizumab, norepinephrine, phenylephrine, vasopressin, atracurium, propofol and fentanyl.

A transthoracic echocardiogram (TTE) showed a vigorous ejection fraction of 70--75% with no regional wall motion abnormalities ([Fig. 4](#f4-1672-1-12952-1-10-20200422){ref-type="fig"}).

Repeat troponins obtained 6 hours apart were 0.056 ng/ml, 0.123 ng/ml and 0.11 ng/ml, respectively. A repeat ECG after 12 hours showed resolution of the ST elevation ([Fig. 5](#f5-1672-1-12952-1-10-20200422){ref-type="fig"}). Unfortunately, patient did not recover and died 24 hours later.

Case 2
------

A 71-year-old female patient with a medical history of multiple myeloma treated with bortezomib, was admitted with a 1-day history of fever, cough and dyspnoea. She tested positive for SARS-CoV-2. Her initial ECG at presentation is shown in [Fig. 6](#f6-1672-1-12952-1-10-20200422){ref-type="fig"}.

On day 2 of admission, the patient became acutely hypotensive and hypoxic with a blood pressure of 70/41 mmHg, a heart rate of 125 beats per minute, a respiratory rate of 33 breaths per minute and oxygen saturation of 70% on 4 l/min of oxygen by nasal cannula. Her chest x-ray showed bilateral alveolar and interstitial opacities ([Fig. 7](#f7-1672-1-12952-1-10-20200422){ref-type="fig"}). She was intubated, initiated on mechanical ventilation and transferred to the MICU for further treatment including vasopressor support. A repeat ECG showed new 1 mm ST elevation in leads V2--V6 with associated Q waves in leads V4--V6 ([Fig. 8](#f8-1672-1-12952-1-10-20200422){ref-type="fig"}).

Again, due to the patient's life-threatening respiratory failure, it was decided not to pursue reperfusion therapy. After completing loading doses, she was started on aspirin 81 mg, clopidogrel 75 mg and a heparin drip. Her other medications included azithromycin, cefepime, vancomycin, tocilizumab, norepinephrine, phenylephrine, midazolam and fentanyl. A TTE showed an ejection fraction of 65--70% with no regional wall motion abnormalities ([Fig. 9](#f9-1672-1-12952-1-10-20200422){ref-type="fig"}).

The patient's baseline troponin of 1.6 ng/ml declined to 1.5 ng/ml after 6 hours and then to 1.1 ng/ml after another 6 hours. A repeat ECG after 12 hours showed complete resolution of the ischaemic changes ([Fig. 10](#f10-1672-1-12952-1-10-20200422){ref-type="fig"}). Patient was still on mechanical ventilation at the time of writing.

DISCUSSION
==========

We describe two cases of transient ST elevation on ECG in patients with normal left ventricular (LV) function and COVID-19. All previously described cases of COVID-19-related ST elevation involved patients with fulminant myocarditis and a severely reduced LV ejection fraction^\[[@b2-1672-1-12952-1-10-20200422]--[@b5-1672-1-12952-1-10-20200422]\]^. These cases add to our understanding of cardiac involvement in active COVID-19, especially given the uncertainty in proceeding with invasive coronary angiography and the need to balance staff exposure with patient benefit ^\[[@b6-1672-1-12952-1-10-20200422]\]^.

Possible explanations for the findings in our patients include focal myocarditis from SARS-CoV-2 infection or a type 2 myocardial infarction from severe hypoxia and hypotension ^\[[@b4-1672-1-12952-1-10-20200422],\ [@b5-1672-1-12952-1-10-20200422]\]^. Acute coronary syndrome type 1 also remains a possibility given the systemic proinflammatory stimulation and hypercoagulability in patients with acute COVID-19 ^\[[@b7-1672-1-12952-1-10-20200422]\]^. Management of patients should be based on a multidisciplinary approach and any reperfusion therapy should follow the guidelines of the American College of Cardiology's Interventional Council and the Society of Cardiovascular Angiography and Intervention ^\[[@b6-1672-1-12952-1-10-20200422]\]^.
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![Baseline ECG showing non-specific T wave changes but no ST segment elevation](1672_Fig2){#f2-1672-1-12952-1-10-20200422}

![ECG showing ST segment elevation in leads I, aVL and V1--V4, and reciprocal ST depression in leads II, III and aVF](1672_Fig3){#f3-1672-1-12952-1-10-20200422}

![Transthoracic echocardiogram (parasternal long-axis view) showing an ejection fraction of 70--75% with no regional wall motion abnormalities](1672_Fig4){#f4-1672-1-12952-1-10-20200422}

![Repeat ECG after 12 hours showing resolution of ST elevation without any intervention](1672_Fig5){#f5-1672-1-12952-1-10-20200422}

![Initial ECG showing first-degree heart block but no ST changes suggestive of ischaemia](1672_Fig6){#f6-1672-1-12952-1-10-20200422}

![Chest x-ray of female patient showing bilateral diffuse lung opacities consistent with acute respiratory distress syndrome](1672_Fig7){#f7-1672-1-12952-1-10-20200422}

![Repeat ECG showing new 1 mm ST elevation in leads V2--V6 with associated Q waves in leads V4--V6](1672_Fig8){#f8-1672-1-12952-1-10-20200422}

![Transthoracic echocardiogram (long-axis view) showing ejection fraction of 65--70% with no wall motion abnormalities](1672_Fig9){#f9-1672-1-12952-1-10-20200422}

![Repeat ECG after 12 hours showing resolution of ST elevation](1672_Fig10){#f10-1672-1-12952-1-10-20200422}
